Objective To develop an evidence-based guideline to help clinicians make decisions about
when and how to safely taper and stop benzodiazepine receptor agonists (BZRAs); to focus …

Objective To develop an evidence-based guideline to help clinicians make decisions about
when and how to safely taper or stop proton pump inhibitors (PPIs); to focus on the highest …

Objective To develop an evidence-based guideline to help clinicians make decisions about
when and how to safely taper and stop antipsychotics; to focus on the highest level of …

Deprescribing can be defined as the process of withdrawal or dose reduction of medications
which are considered inappropriate in an individual. The aim of this narrative review is to …

Objective To develop an evidence-based guideline to help clinicians make decisions about
when and how to safely taper, stop, or switch antihyperglycemic agents in older adults. …

Background Proton pump inhibitors (PPIs) are a class of medications that reduce acid
secretion and are used for treating many conditions such as gastroesophageal reflux disease (…

Unnecessary polypharmacy continues to be a problem among older adults. The field of
deprescribing (planned, supervised process of medication discontinuation) aims to address this …

Inappropriate prescribing and polypharmacy in older persons are associated with increased
risks of falls, adverse drug events, hospital admissions, and death. 1-3 Given these potential …

Proton pump inhibitors ( PPI s) are widely used, and concerns about overuse have been
raised. Therefore, side effects are important to be aware of and several suggested side effects …

Self-assembled monolayer films of (3-mercaptopropyl)trimethoxysilane (3MPT) and their
hydrolysis products on Ag and Au surfaces are characterized using Raman spectroscopy, FTIR …